CATALYST PHARMACEUTICALS, INC. (CPRX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$7.68M2010: -$3.76M2011: -$4.99M2012: -$5.14M2017: -$13.74M2018: -$26.15M2019: $34.61M2020: $45.03M2021: $60.37M2022: $116.05M2023: $143.60M2024: $239.81M2025: $208.67M$208.67M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$208.67M-13.0%
2024$239.81M+67.0%
2023$143.60M+23.7%
2022$116.05M+92.2%
2021$60.37M+34.1%
2020$45.03M+30.1%
2019$34.61M+232.4%
2018-$26.15M-90.3%
2017-$13.74M
2012-$5.14M-3.1%
2011-$4.99M-32.7%
2010-$3.76M+51.1%
2009-$7.68M